Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.60%9.02M | -0.81%7.56M | 5.79%9.01M | -3.76%37.4M | 26.70%12.52M | -12.99%8.79M | 150.44%7.63M | -46.22%8.51M | -31.73%38.86M | -12.34%9.88M |
| Cost of revenue | -9.72%5.67M | 1.49%5.52M | -13.67%5.13M | -25.36%25.32M | -5.48%7.8M | -25.53%6.28M | 83.31%5.44M | -54.44%5.95M | -16.32%33.93M | -12.89%8.25M |
| Gross profit | 33.47%3.35M | -6.53%2.05M | 50.92%3.87M | 144.65%12.08M | 189.52%4.72M | 50.39%2.51M | 2,638.75%2.19M | -7.53%2.57M | -69.86%4.94M | -9.42%1.63M |
| Operating expense | -3.57%3.27M | -2.67%3.65M | -18.82%2.98M | 1.01%17.76M | 4.84%6.85M | -27.05%3.39M | -8.24%3.75M | -3.67%3.67M | 64.22%17.58M | 94.43%6.53M |
| Selling and administrative expenses | 5.27%3.22M | -10.59%3.29M | -13.12%3.15M | -8.56%16.56M | -29.45%4.01M | -30.57%3.06M | -9.33%3.68M | -8.80%3.63M | 41.58%18.11M | 41.27%5.68M |
| -Selling and marketing expense | -45.83%65K | -40.21%116K | -58.93%46K | -9.60%470.62K | -36.62%45K | -19.46%120K | 52.76%194K | -36.00%112K | 60.57%520.57K | -44.62%71K |
| -General and administrative expense | 7.36%3.15M | -8.95%3.18M | -11.66%3.11M | -8.53%16.09M | -29.36%3.97M | -30.96%2.94M | -11.34%3.49M | -7.54%3.52M | 41.09%17.59M | 44.10%5.61M |
| Other operating expenses | -53.01%375K | 32.14%999K | 15.43%561K | 462.28%2.76M | 140.12%2.9M | 37.11%798K | 42.11%756K | 134.78%486K | 307.25%490.35K | 313.38%1.21M |
| Total other operating income | -30.65%319K | -6.85%639K | 65.46%733K | 53.22%1.55M | -81.32%68K | 38.97%460K | 36.11%686K | 18.45%443K | -53.97%1.01M | 268.73%364K |
| Operating profit | 108.83%78K | -2.76%-1.6M | 180.40%890K | 55.06%-5.68M | 56.66%-2.12M | 70.39%-883K | 61.08%-1.56M | -6.65%-1.11M | -322.91%-12.65M | -214.49%-4.9M |
| Net non-operating interest income (expenses) | -6.85%-78K | 26.72%-85K | -28.57%-90K | 318.07%509.2K | 1,598.11%794K | -37.74%-73K | -132.00%-116K | -20.69%-70K | -13.00%-233.5K | 23.90%-53K |
| Non-operating interest income | -35.29%11K | -61.11%7K | -14.29%6K | 938.22%929.3K | 4,827.78%887K | -26.09%17K | -35.71%18K | -66.67%7K | -26.81%89.51K | -25.91%18K |
| Non-operating interest expense | -1.11%89K | -31.34%92K | 24.68%96K | 30.06%420.1K | 30.99%93K | 18.42%90K | 71.79%134K | -2.53%77K | -1.80%323.01K | -24.42%71K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -602.74%-1.09M | -602.30%-1.09M | -99.25%216.82K | 217K | ||||||
| Less:Write off | ---- | ---- | ---- | 602.74%1.09M | 602.30%1.09M | ---- | ---- | ---- | -197.50%-216.82K | ---217K |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 0 | -0.72%-1.69M | 167.97%800K | 50.53%-6.26M | 48.90%-2.42M | 68.50%-956K | 58.70%-1.68M | -7.39%-1.18M | -136.91%-12.66M | -117.40%-4.73M |
| Income tax | 0 | 0 | 0 | 66.59%-157.38K | 102.73%17K | -112K | 0 | 0 | -123.82%-471.08K | -104.64%-622K |
| Net income | 0 | -0.72%-1.69M | 167.97%800K | 49.91%-6.11M | 40.76%-2.44M | 72.19%-844K | 56.78%-1.68M | 18.04%-1.18M | -137.72%-12.19M | -114.94%-4.11M |
| Net income continuous operations | --0 | -0.72%-1.69M | 167.97%800K | 49.91%-6.11M | 40.76%-2.44M | 72.19%-844K | 56.78%-1.68M | 18.04%-1.18M | -137.72%-12.19M | -114.94%-4.11M |
| Noncontrolling interests | 160.63%134K | 958.33%254K | 159.73%270K | 58.12%-943.61K | 77.81%-89K | 68.34%-221K | 103.36%24K | 1.74%-452K | -860.01%-2.25M | -70.85%-401K |
| Net income attributable to the company | 78.49%-134K | -14.24%-1.94M | 173.10%530K | 48.05%-5.16M | 36.76%-2.35M | 73.34%-623K | 46.25%-1.7M | 25.72%-725K | -130.52%-9.94M | -113.37%-3.71M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 78.49%-134K | -14.24%-1.94M | 173.10%530K | 48.05%-5.16M | 36.76%-2.35M | 73.34%-623K | 46.25%-1.7M | 25.72%-725K | -130.52%-9.94M | -113.37%-3.71M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 81.82%-0.0002 | -16.13%-0.0036 | 176.92%0.001 | 48.09%-0.0095 | 36.76%-0.0043 | 74.42%-0.0011 | 46.55%-0.0031 | 27.78%-0.0013 | -120.91%-0.0183 | -109.30%-0.0068 |
| Diluted earnings per share | 81.82%-0.0002 | -16.13%-0.0036 | 169.23%0.0009 | 48.09%-0.0095 | 36.76%-0.0043 | 74.42%-0.0011 | 46.55%-0.0031 | 27.78%-0.0013 | -121.40%-0.0183 | -109.56%-0.0068 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.